Breakdown of self-tolerance and aberrant cytokine axes (IL-17/23, type I IFN) lead to sustained tissue damage in diseases such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, and systemic lupus erythematosus [1,32,39]. This evidence concerns the gene IL17A and psoriasis.